No products
New
AVALIABLE IN 24/48 H
Warning: Last items in stock!
Availability date:
Wonderful selection of crosses that has resulted in this wonderful plant low in THC and a high percentage of high quality CBD. Perfect for the treatment of various pathologies and suitable for all audiences, even those who have not used cannabis before. Very suitable for the manufacture of ointments, oils, etc. They can produce between 450-600gr7m2 in 9-10 weeks.
Seed Type | Feminized - Photoperiod |
Cross | Y Griega CBD x Cherry Wine CBD |
Indica/Sativa | Indica/Sativa Hybrid |
THC | 0.3% |
CBD | Very High |
Flowering (indoors) | 9-10 weeks |
Harvest (outdoors) | Mid October |
Height Outdoor | 200 cm |
Yield | 450 g/m2 (indoor) +600 g/plant (outdoor) |
After lots of hard work, crossing and interbreeding our Y Griega CBD, we succesfully developped a strain with very high levels of CBD, and low THC levels that are mostly below 0,3%. After lots of crosses with the very known Cherry Wine CBD, we managed to keep this strain’s features on all its diffe-rent phenotypes. This makes this genetic a good choice for people looking to complement some medical treatments. Due to its low THC levels, it is re-commended to all kind of users, including old people, people with no expe-rience, or people with low tolerance levels. As it has no psychoactive effect, this plant is suitable for the making of tinctures, edibles, and oils. The plant’s structure is similar to Y Griega CBD, but there has been an improvement on the production of buds and trichomes. The aroma and flavor still have strong citrus hints, with nuances of Sweet wine and cherry. To enhance the flavour and aroma of Y Griega CBD 2.0, we strongly recommend the use of organic nutrients over mineral ones
● 50% Indica 50% Sativa
● Indoor vegetative period: 3-4 weeks
● Indoor flowering period: 9-10 weeks
● Indoor production / m2: 450 gr
● Height outdoors: 2 meters
● Harvest outdoors: mid-October
● Outdoor production / plant: +600 gr
● Genotype: Y Griega CBD x Cherry Wine CBD
● THC: Low
● CBD: High
No customer comments for the moment.